- COMMENT
AI can help to speed up drug discovery — but only if we give it the right data
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 621, 467-470 (2023)
doi: https://doi.org/10.1038/d41586-023-02896-9
References
Thomas, D. et al. Clinical Development Success Rates and Contributing Factors 2011–2020 (BIO, QLS & Informa, 2021).
Fernando, K. et al. Drug Discov. Today 27, 697–704 (2022).
Reck, M. et al. J. Clin. Oncol. 39, 2339–2349 (2021).
Deshaies, R. J. Nature 580, 329–338 (2020).
Mak, K.-K. & Pichika, M. R. Drug Discov. Today 24, 773–780 (2019).
Rieke, N. et al. NPJ Digit. Med. 3, 119 (2020).
Raybould, M. I. J. et al. Proc. Natl Acad. Sci. USA 116, 4025–4030 (2019).
Jain, T. et al. Proc. Natl Acad. Sci. USA 114, 944–949 (2017).
Heyndrickx, W. et al. Preprint at ChemRxiv https://doi.org/10.26434/chemrxiv-2022-ntd3r (2022).
Bailey, M. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.07.26.550653 (2023).
Olsen, T. H., Boyles, F. & Deane, C. M. Protein Sci. 31, 141–146 (2022).
Competing Interests
All co-authors are employees and stockholders of Amgen, Inc.